Neurogene Inc. (NGNE)
USD 15.31
(-0.87%)
USD 15.31
(-0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 25 Million |
| Cost of Revenue | 3.26 Million | 3.19 Million | 2.27 Million | 1.82 Million | 340 Thousand | - |
| Gross Profit | -3.26 Million | -3.19 Million | -2.27 Million | -1.82 Million | -340 Thousand | 25 Million |
| Operating Expenses | 55.58 Million | 56.51 Million | 50.53 Million | 39.73 Million | 24.1 Million | 48.52 Million |
| Selling, General and Administrative Expenses | 11.18 Million | 9.01 Million | 8.27 Million | 15.38 Million | 17.78 Million | 15.73 Million |
| Research and Development Expenses | 44.39 Million | 47.5 Million | 42.26 Million | 24.34 Million | 6.31 Million | 32.78 Million |
| Other Expenses | - | -7000.00 | - | - | - | - |
| Cost and Expenses | 55.58 Million | 56.51 Million | 50.53 Million | 41.55 Million | 24.44 Million | 48.52 Million |
| Operating Income | -55.58 Million | -56.51 Million | -50.53 Million | -41.55 Million | -24.44 Million | -23.52 Million |
| Interest Expense | 12 Thousand | 2000.00 | - | - | 1000.00 | 4000.00 |
| Income Tax Expense | - | -5000.00 | 17 Thousand | -1.00 | 168.14 Thousand | - |
| Earnings before Tax | -36.31 Million | -55.18 Million | -50.51 Million | -33.27 Million | -69.44 Million | -31.58 Million |
| Net Income | -36.31 Million | -55.18 Million | -50.51 Million | -33.27 Million | -69.44 Million | -31.58 Million |
| Earnings Per Share Basic | -2.83 | -4.30 | -0.92 | -0.64 | -2.57 | -1.34 |
| Earnings Per Share Diluted | -2.83 | -4.30 | -0.92 | -0.64 | -2.57 | -1.34 |
| Weighted Average Shares Outstanding | 12.82 Million | 12.82 Million | 55.04 Million | 51.82 Million | 27.03 Million | 23.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.82 Million | 12.82 Million | 55.04 Million | 51.82 Million | 27.03 Million | 23.51 Million |
| Gross Margin | - | - | - | - | - | 1.00 |
| EBIT Margin | - | - | - | - | - | -0.94 |
| Profit Margin | - | - | - | - | - | -1.26 |
| EBITDA | -52.28 Million | -51.99 Million | -49.58 Million | -31.45 Million | -69.1 Million | -31.58 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -0.94 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 925 Thousand | - | - | - | - | - |
| Cost of Revenue | 817 Thousand | 825 Thousand | 3.26 Million | 1.89 Million | 381 Thousand | 371 Thousand |
| Gross Profit | 108 Thousand | -825 Thousand | -3.26 Million | -1.89 Million | -381 Thousand | -371 Thousand |
| Operating Expenses | 20.24 Million | 17.95 Million | 55.58 Million | 34.61 Million | 5.18 Million | 12.59 Million |
| Selling, General and Administrative Expenses | 4.49 Million | 4.41 Million | - | 2549.00 | 4.57 Million | 2.27 Million |
| Research and Development Expenses | 15.74 Million | 13.54 Million | - | 34.61 Million | 617 Thousand | 10.32 Million |
| Other Expenses | -389 Thousand | -459 Thousand | -28 Thousand | - | - | -4000.00 |
| Cost and Expenses | 21.05 Million | 18.77 Million | 55.58 Million | 36.51 Million | 5.56 Million | 12.59 Million |
| Operating Income | -20.13 Million | -18.77 Million | -55.58 Million | -36.51 Million | -5.56 Million | -12.59 Million |
| Interest Expense | 4000.00 | -3000.00 | 12 Thousand | 29 Thousand | - | 3000.00 |
| Income Tax Expense | -1.00 | -1.00 | -16 Thousand | 1.85 Million | 420.58 Thousand | -740 Thousand |
| Earnings before Tax | -18.49 Million | -16.92 Million | -36.31 Million | -15.5 Million | -4.52 Million | -11.86 Million |
| Net Income | -18.49 Million | -16.92 Million | -36.31 Million | -15.5 Million | -4.52 Million | -11.86 Million |
| Earnings Per Share Basic | -1.09 | -1.00 | - | -1.21 | -0.41 | -0.21 |
| Earnings Per Share Diluted | -1.09 | -1.00 | - | -1.21 | -0.41 | -0.21 |
| Weighted Average Shares Outstanding | 16.94 Million | 16.9 Million | 12.82 Million | 12.82 Million | 11.1 Million | 56.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.94 Million | 16.9 Million | 12.82 Million | 12.82 Million | 11.1 Million | 56.15 Million |
| Gross Margin | 0.12 | - | - | - | - | - |
| EBIT Margin | -20.88 | - | - | - | - | - |
| Profit Margin | -19.99 | - | - | - | - | - |
| EBITDA | -19.31 Million | -17.95 Million | - | -34.61 Million | -5.18 Million | -11.85 Million |
| Earnings Before Tax Margin | -21.77 | - | - | - | - | - |
PCLOF
8620
CBSTF
BTURF
SBOK
GLOBALVECT